AVXL

Anavex Life Sciences Corp.

 
Common Stock SEC Reporting - Current
OTCQX U.S. OTCQX Advisor: K&L Gates LLP
Contact Info
  • 51 West 52nd Street
  • 7th Floor
  • New York, NY 10019

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2014 10-Q
CIK 0001314052
Fiscal Year End 9/30
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: NV, USA
Year of Inc. 2006
Employees 3 a/o Dec 10, 2014
Company Officers/Contacts
Christopher Missling President, CEO, CFO
Christine Payne IR
Company Directors
Christopher Missling Chairman
Elliot Favus
Bernd Metzner
Athanasios Skarpelos
Company Notes
  • Formerly=Thrifty Printing, Inc. until 1-07
Service Providers
OTCQX Advisor
K&L Gates LLP
200 S. Biscayne Blvd
Suite 3900
Miami, FL, 33131
USA

Accounting/Auditing Firm
BDO USA, LLP
135 West 50th Street
New York, NY, 10020
United States

Legal Counsel
K&L Gates LLP
200 S. Biscayne Blvd
Suite 3900
Miami, FL, 33131
United States

Investor Relations Firm
Not Available
AVXL Security Details
Share Structure
Market Value1 $9,423,080 a/o Dec 19, 2014
Shares Outstanding 54,594,904 a/o Dec 03, 2014
Float Not Available
Authorized Shares 150,000,000 a/o Sep 30, 2014
Par Value 0.001
Shareholders
Shareholders of Record 89 a/o Dec 30, 2013
Short Selling Data
Short Interest 808,209 (-16.05%)
Nov 28, 2014
Significant Failures to Deliver No

1Market Value calculated only for respective security